Efficacy News and Research

RSS
Research findings could lead to improved treatment for neuropathic pain

Research findings could lead to improved treatment for neuropathic pain

Neurological researchers study promising new treatment for deadly brain tumors

Neurological researchers study promising new treatment for deadly brain tumors

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Smokers trying to quit will have better experience with varenicline, study finds

Smokers trying to quit will have better experience with varenicline, study finds

Chelation therapy with drug disodium EDTA reduces risk of heart attack

Chelation therapy with drug disodium EDTA reduces risk of heart attack

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Novel sensor improves success rate in diagnosing dysphagia

Novel sensor improves success rate in diagnosing dysphagia

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

Academic medical centers launch ASD sub-registry within ResearchMatch

Academic medical centers launch ASD sub-registry within ResearchMatch

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Biomedical researcher discovers new technique to measure oxygen in individual red blood cells

Biomedical researcher discovers new technique to measure oxygen in individual red blood cells

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

New guidance highlights risk factors and treatments for osteoporosis in postmenopausal women

New guidance highlights risk factors and treatments for osteoporosis in postmenopausal women

Anti-inflammatory drug naproxen may exhibit antiviral activity against influenza A virus

Anti-inflammatory drug naproxen may exhibit antiviral activity against influenza A virus

LMU researchers identify microRNA that offers promising target for new therapies

LMU researchers identify microRNA that offers promising target for new therapies

Study shows physically active healthcare providers more likely to advise patients to lead active lifestyle

Study shows physically active healthcare providers more likely to advise patients to lead active lifestyle

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.